Kahne, Daniel

Clinical studies have suggested a relationship between low cerebrospinal fluid homovanillic acid, a measure reflecting DA activity in the PFC, and poor performance at tasks involving WM in schizophrenia (Kahn et al., 1994 Weinberger et al., 1998). DA agonists have beneficial effects on the pattern of prefrontal activation measured with PET during these tasks (Daniel et al., 1991 Dolan et al., 1995). 

By J. Bradford Bowzard, J. Daniel Sharer, and Richard A. Kahn... 

---